LBSR

0.015740.18%
PO

Peter O’Heeron

Chairman, Secretary & Treasurer

Mr. Peter O'Heeron, MSHA, also known as Pete, is the Founder, Chairperson & Chief Executive Officer at FibroBiologics, Inc. (Formerly, FibroBiologics LLC) since April 2021. Mr. O’Heeron is also the Founder of FibroGenesis and has served as the Chief Executive Officer of FibroGenesis since January 2006. Since September 2012, Mr. O’Heeron has also served as Chairman of the Board, Secretary and Treasurer of Liberty Star Uranium & Metals Corp. He founded SpinalCyte, LLC. As a seasoned leader he has medical technology and biotech development experience. He founded an operational investment group, Advanced Medical Technologies, LLC, that identified early-stage opportunities in the medical field with strong intellectual property potential in 2006. Prior to that, he founded NeoSurg Technologies in 1998. He served as President and Chief Executive Officer of Neosurg Technologies Inc. NeoSurg Technologies developed the T2000 Minimally Invasive Access System and was sold to Cooper Surgical in 2006. He was employed by SCH Healthcare Corporation/St. John Hospital from 1987 to 1995, as the Assistant Administrator for Professional Services and Product Development. He Developed a variety of new programs and products such as the St. John Sports Medicine Facility, the Sports Medicine Joint Venture, Professional Office Building Development in Houston and California, the St. John Magnetic Resonance Imaging Center and the Primary Care Network. He served as a Director of Neosurg Technologies Inc. Mr. O’Heeron also previously served in a variety of executive-level positions at Christus Health Care Corporation from 1988 until 1995 and has provided strategic advisory services to healthcare companies in the areas of biologics, advanced surgical instrumentation and telemedicine. He received Degree from Texas State University with a BS in Healthcare Administration and a minor in Business Administration in 1986. He received his Master’s in Healthcare Administration from the University of Houston-Clear Lake in 1988. Mr. O’Heeron completed Executive Management Certification in Mergers and Acquisition from University of Chicago. He is a preeminent biopharma inventor, with over 300 patents issued and pending in the areas of biologics, cell therapy and medical devices. He is qualified to serve as a member of the Board based on his experience, qualifications, attributes and skills, including co-founding company and his executive leadership experience in the biotechnology industry.

Positions